Want to join the conversation?
$SJM said its 2016 non-GAAP EPS was $6.57, including a one-time $0.42 per share non-cash benefit. This compares to the company's most recent guidance of $5.84-5.94, which excluded the tax benefit. The company generated free cash flow of $1.26Bil, which is well above the original estimate. $SJM reduced its total debt by nearly $750MM in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?